Search Results 451-460 of 13943 for Moderate acute malnutrition

  1. EndovaSCularTreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) - Mayo Clinic

    The purpose of this study is to show that acute, rapid, revascularization in patients with acute ... Patient has a major co-morbid illness, such as moderate or ...

  2. Lintuzumab-Ac225 In Older Acute Myeloid Leukemia (AML) Patients - Mayo Clinic

    About this study. The study is a multicenter, open label Phase I/II trial. 1. Establish the MTD of fractionated doses of Lintuzumab-Ac225 in combination ...

  3. Pemigatinib To Treat Metastatic Or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Known hypersensitivity or severe reaction to an ... Current use of prohibited medication -Use of any potent CYP3A4 inhibitors or inducers or moderate ... Co-morbid ...

  4. A Study to Evaluate a Peptide-based Diet in Enteral Nutrition Intolerance - Mayo Clinic

    Any condition that would contraindicate use of the study product (i.e., need for severe fluid restriction, cow's milk protein allergy, fish allergy, other).

  5. A Safety And Efficacy Study Of A Bowel Cleansing Preparation (BLI800) In Pediatric Subjects Undergoing Colonoscopy - Mayo Clinic

    Participation eligibility · Subjects with known or suspected ileus, impaction, severe ulcerative colitis, acute peritonitis, gastrointestinal obstruction, ...

  6. Ginseng As An Intervention To Decrease Cancer-Related Fatigue In Post-Treatment Cancer Survivors - Mayo Clinic

    Psychiatric disorder such as severe depression, manic depressive disorder, obsessive compulsive disorder or schizophrenia. ... Patients with malnutrition, active ...

  7. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor - Mayo Clinic

    A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed ...

  8. Axatilimab Plus Standard Of Care Therapy For The Prevention Of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Cancer, ABRAXAS Trial - Mayo Clinic

    This phase II trial studies how well adding axatilimab to standard of care (SOC) therapy works in preventing graft versus host disease (GVHD) following ...

  9. Safety Study of Inhaled Saline in Acute Lung Injury - Mayo Clinic

    About this study. To determine if an inhaled hypertonic saline solution has any effect on lung function in patients with acute respiratory distress syndrome ...

  10. Doctors and departments - Mayo Clinic

    Mild cognitive impairment (MCI). Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...